Clinical Trial Update: TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx)

View source ↗

Summary

The trial is sponsored by University College London and aims to track the evolution of Non-small cell lung cancer through therapy. It is currently listed as ACT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University College, London | Conditions: Non-small Cell Lung Cancer | Status: ACTIVE_NOT_RECRUITING